Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

Adenomyosis was first described as endometrial glands in the myometrium of the uterus. The current definition of adenomyosis is provided in 1972 'the benign invasion of endometrium into the myometrium, producing a diffusely enlarged uterus which microscopically exhibits ectopic non-neoplastic, endometrial glands and stroma surrounded by the hypertrophic and hyperplastic myometrium

Inclusion Criteria:

• symptomatic adenomyosis
• irregular menstrual bleeding and dysmenorrhea .

Exclusion Criteria:

• asymptomatic patients -
• non-lactating patient
• not desire for pregnancy
• no hormonal treatment more than 6 month even contraception e.g IUD
• no focal lesion of uterus (malignancy ,fibroid or adenxal mass )